2018 - transgenic.co.jp

1 2018 5 23 2342 03-6551-2601 2018 5 23 14 00 14 50 2 2018 3 2018 3 2018 3 2018 23 0 Copyright transgenic Inc.

2 All Rights Reserved. 1 Table of Contents 3 3 III. IV. 2 Copyright transgenic Inc. All Rights Reserved. 3 Copyright transgenic Inc. All Rights Reserved. 3 2017 3 2018 3 2,302,908 3,601,283 1,298,374 1,553,971 2,778,826 1,224,854 748,937 822,457 73,519 594,989 (48,015) 761,903 (55,156 166,913 7,141) 153,948 60,554 93,394 88,272 14,459 73,813 80,694 20,898 59,796 CRO TGBS 3 TGBS Overview of Consolidated Financial Results 2018 3 Copyright transgenic Inc.

3 All Rights Reserved. 4 395 420 299 1,099 1,150 1,000 391 356 412 413 399 395 1,305 199 05001,0001,5002,0002,5003,0003,5004,0002 01620172018 CRO E 2 CRO 3,601 2,302 2,290 Overview of Consolidated Financial Results 2018 3 Copyright transgenic Inc. All Rights Reserved. 5 -50050100150200250300350-200-150-100-500 50100150200201620172018 CRO E 93 CRO TGBS 50 153 60 Overview of Consolidated Financial Results 2018 3 Copyright transgenic Inc.

4 All Rights Reserved. 6 214 232 219 100150200250300201620172018236 242 288 100150200250300201620172018 Cash Flow Cash Flow 1 Cash Flow Cash Flow Cash Flow Overview of Consolidated Financial Results 2018 3 Cash Flow Copyright transgenic Inc. All Rights Reserved. 7 (CRISPR/Cas9) CRO 395,050 420,148 299,045 0100,000200,000300,000400,00020162017201 8( ) 51,098 85,941 -1,417 -10,00010,00030,00050,00070,00090,000110 ,000201620172018( ) Overview of Sales Revenue Genomics Business Copyright transgenic Inc.

5 All Rights Reserved. 8 BSRC CRO ( ) ( ) 1,099,367 1,150,505 1,000,662 0200,000400,000600,000800,0001,000,0001, 200,000201620172018128,580 244,338 128,303 050,000100,000150,000200,000250,000300,0 00201620172018 Overview of Sales Revenue Contract Research Organization Business CRO Copyright transgenic Inc. All Rights Reserved. 9 DTC 13,136 -4,341 63,132 (10,000)010,00020,00030,00040,00050,0006 0,00070,000201620172018( ) ( ) 391,779 356,587 412,355 0100,000200,000300,000400,000500,0002016 20172018 Overview of Sales Revenue Advanced medical Business Copyright transgenic Inc.

6 All Rights Reserved. 10 HPV HPV 413,778 399,294 395,627 0100,000200,000300,000400,000500,0002016 20172018( ) 44,149 3,491 -7,879 -20,000-10,000010,00020,00030,00040,0005 0,000201620172018( ) Overview of Sales Revenue - Pathological Diagnostics Business 11 Copyright transgenic Inc. All Rights Reserved. 3 Copyright transgenic Inc. All Rights Reserved. 12 2018 3 2019 3 3,601,283 8,500,000 299,045 300,000 CRO 1,000,662 1,860,000 M&A 412,355 450,000 395,627 400,000 TGBS 1,505,360 5,500,000 M A 11,768 10,000 (TGBS ) ( ) 3,540,729 (1,460,354) (55,156) 8,200,000 (5,400,000) (40,000)

7 EC 60,554 300,000 TGBS 1 14,459 250,000 1, 20,898 150,000 Consolidated Business Forecast for the Year Ending March 2019 2019 3 ( ) TGBS CRO TGBS Copyright transgenic Inc. All Rights Reserved. 13 02,000,0004,000,0006,000,0008,000,00010, 000,0002018/32019/32020/3 CRO TGBS01,000,0002,000,0003,000,0004,000,00 05,000,0002018/32019/32020/3 CRO TGBSE TGBS E E E 6 EC 8 Consolidated Business Forecast for the Year Ending March 2019 2019 3 Copyright transgenic Inc.

8 All Rights Reserved. 14 (200,000)(100,000)0100,000200,000300,000 400,000500,000600,0002012/32013/32014/32 015/32016/32017/32018/32019/32020/3 TGBS CRO CRO CRO HPV M&A CRO TGBS 3 V Consolidated Business Forecast for the Year Ending March 2019 2019 3 15 Copyright transgenic Inc. All Rights Reserved. III.

9 Copyright transgenic Inc. All Rights Reserved. 16 100% 100% 100% 100% SMO 40% TG 100% 100% 100% 33 BSRC 230 80 27 55 CRO Topics of Business 2018 4 1 Copyright transgenic Inc. All Rights Reserved. 17 1998 4 3.

10 240 33 231 2-3-36 7-1-14 1-7- 2000 8 30 19 2-7-3 2000 9 100 52 9 15-28-196 1-7- 2001 11 10 2 452 1 2018 3 100 62 582 2 2000 9 22 4 7-1-14 1994 7 5 2-11-5 2017 11 10 5 2-3-36 2013 4 50 49 1-7-1 452 1 Topics of Business 2018 4 1 Copyright transgenic Inc.